Advertisement Filligent wins CE Mark for new anti-infective face mask - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Filligent wins CE Mark for new anti-infective face mask

Hong Kong-based biotechnology company Filligent has received CE certification for its anti-infective medical face mask, the BioMask.

The BioMask is said to be the first in a series of new products in Filligent’s anti-microbial personal care range, BioFriend, to be launched during 2009. By complying with the European Community’s medical devices directive 93/42/EEC, Filligent has met the stringent EU requirements for design, efficacy and safety of its innovative, germ-killing BioMask.

According to the company, the BioMask is based on an ‘intelligent filtration’ technology and is fabricated from a scientifically designed and tested multilayer material which has in its internal structure a unique active layer which has highly targeted anti-microbial properties. This active layer aggressively detects, traps, and then rapidly kills pathogens, within minutes of contact.

With CE certification now in hand, Filligent expects widespread adoption of the mask by medical institutions and governments during 2009. The BioMask will also be available to consumers for direct retail purchase in drugstore chains in Hong Kong and China during the same period. The company expects FDA classification in 2009 later.